Latest News

Local News

Ovarian cancer sufferers provided new PBS hope

PINKRIBBONPIXA.jpg
Local women living with Ovarian cancer linked to the Bracca gene mutation now have expanded access to treatment under the Pharmaceutical Benefits Scheme.
Ovarian cancer remains the most common cause of gynaecological cancer deaths in Australia with the disease claiming the life of one woman every eight hours.
Krystal Barter from support organisation Pink Hope said the expanded listing for Lynparza has been welcome news for patients and their loved ones. 
"It is really important for local women living with Ovarian cancer to have access to expanded treatments so if they have any concerns please reach out to Pink Hope Ovarian Cancer Australia or their health care team", she said.